Fortrea (FTRE) Competitors $5.80 +1.14 (+24.46%) Closing price 04:00 PM EasternExtended Trading$5.75 -0.05 (-0.86%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FTRE vs. LFST, ARDT, NHC, TDOC, VRDN, GRAL, AHCO, AGL, PNTG, and AVAHShould you be buying Fortrea stock or one of its competitors? The main competitors of Fortrea include LifeStance Health Group (LFST), Ardent Health (ARDT), National HealthCare (NHC), Teladoc Health (TDOC), Viridian Therapeutics (VRDN), GRAIL (GRAL), AdaptHealth (AHCO), Agilon Health (AGL), The Pennant Group (PNTG), and Aveanna Healthcare (AVAH). These companies are all part of the "healthcare" industry. Fortrea vs. Its Competitors LifeStance Health Group Ardent Health National HealthCare Teladoc Health Viridian Therapeutics GRAIL AdaptHealth Agilon Health The Pennant Group Aveanna Healthcare LifeStance Health Group (NASDAQ:LFST) and Fortrea (NASDAQ:FTRE) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation. Which has more risk and volatility, LFST or FTRE? LifeStance Health Group has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. Comparatively, Fortrea has a beta of 1.76, meaning that its stock price is 76% more volatile than the S&P 500. Which has preferable earnings & valuation, LFST or FTRE? LifeStance Health Group has higher earnings, but lower revenue than Fortrea. LifeStance Health Group is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifeStance Health Group$1.25B1.31-$57.44M-$0.10-42.00Fortrea$2.70B0.19-$328.50M-$8.79-0.66 Is LFST or FTRE more profitable? LifeStance Health Group has a net margin of -2.78% compared to Fortrea's net margin of -29.43%. Fortrea's return on equity of 2.84% beat LifeStance Health Group's return on equity.Company Net Margins Return on Equity Return on Assets LifeStance Health Group-2.78% -2.47% -1.69% Fortrea -29.43%2.84%1.06% Do analysts recommend LFST or FTRE? LifeStance Health Group presently has a consensus target price of $8.50, indicating a potential upside of 102.38%. Fortrea has a consensus target price of $14.00, indicating a potential upside of 141.38%. Given Fortrea's higher possible upside, analysts plainly believe Fortrea is more favorable than LifeStance Health Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LifeStance Health Group 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.83Fortrea 2 Sell rating(s) 12 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86 Does the media prefer LFST or FTRE? In the previous week, Fortrea had 37 more articles in the media than LifeStance Health Group. MarketBeat recorded 43 mentions for Fortrea and 6 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.54 beat Fortrea's score of 0.03 indicating that LifeStance Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Fortrea 2 Very Positive mention(s) 2 Positive mention(s) 35 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral Do institutionals & insiders believe in LFST or FTRE? 85.5% of LifeStance Health Group shares are owned by institutional investors. 6.6% of LifeStance Health Group shares are owned by insiders. Comparatively, 0.4% of Fortrea shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryLifeStance Health Group beats Fortrea on 10 of the 16 factors compared between the two stocks. Get Fortrea News Delivered to You Automatically Sign up to receive the latest news and ratings for FTRE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FTRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTRE vs. The Competition Export to ExcelMetricFortreaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$421.73M$2.96B$5.57B$9.41BDividend YieldN/A2.47%4.00%4.03%P/E Ratio11.6520.5328.3219.89Price / Sales0.19318.67446.45195.77Price / Cash2.9640.8024.9928.17Price / Book0.387.808.325.73Net Income-$328.50M-$55.10M$3.24B$258.18M7 Day Performance22.88%6.40%4.20%3.92%1 Month Performance9.02%16.84%10.16%14.31%1 Year Performance-78.37%3.12%34.69%17.29% Fortrea Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTREFortrea3.7446 of 5 stars$5.80+24.5%$14.00+141.4%-82.1%$421.73M$2.70B11.6515,500Trending NewsGap UpLFSTLifeStance Health Group3.1115 of 5 stars$4.17-1.2%$8.50+103.8%-24.2%$1.64B$1.25B-41.7010,218News CoverageARDTArdent Health3.8325 of 5 stars$10.93-1.6%$20.30+85.8%-36.8%$1.59B$5.97B6.7024,900NHCNational HealthCareN/A$97.31-0.1%N/A-21.8%$1.50B$1.37B12.1912,400News CoverageTDOCTeladoc Health2.6375 of 5 stars$8.34+3.5%$9.65+15.8%-8.3%$1.41B$2.57B-1.415,500News CoverageVRDNViridian Therapeutics3.2131 of 5 stars$16.79+1.6%$37.56+123.7%+16.0%$1.35B$300K-4.3650GRALGRAIL0.5896 of 5 stars$34.35-2.4%$31.50-8.3%+107.2%$1.27B$125.60M-0.561,360Positive NewsAHCOAdaptHealth3.7467 of 5 stars$9.15-0.8%$13.40+46.4%-14.0%$1.24B$3.26B16.0510,500Positive NewsAGLAgilon Health2.7619 of 5 stars$2.15+1.2%$4.71+119.8%-68.9%$877.58M$6.06B-3.641,076PNTGThe Pennant Group3.41 of 5 stars$23.24-0.8%$33.80+45.4%-14.4%$807.61M$695.24M30.587,000AVAHAveanna Healthcare2.4284 of 5 stars$4.03+1.8%$5.25+30.3%+17.2%$772.57M$2.02B201.5033,500News CoverageAnalyst Upgrade Related Companies and Tools Related Companies LFST Competitors ARDT Competitors NHC Competitors TDOC Competitors VRDN Competitors GRAL Competitors AHCO Competitors AGL Competitors PNTG Competitors AVAH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FTRE) was last updated on 7/22/2025 by MarketBeat.com Staff From Our PartnersTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBitcoin just humbled Jeff BezosBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortrea With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.